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Abstract
Background: Low grade fibromyxoid sarcomas (LGFMS) are very rarely seen. They commonly
arise from deep soft tissues of the lower extremities. Very few cases of intra-abdominal location
have been reported.
Case presentation: We report a 37 year old man who presented with an abdominal mass and
dragging pain. Pre-operative imaging suggested the possibility of a subcapsular hemangioma of liver.
Conclusions: Laparoscopy was useful to locate the tumor as arising from falciform ligament and
made the subsequent surgery simpler. This is one of the large fibromyxoid sarcomas to be
reported.
Background
Low grade fibromyxoid sarcomas (LGFMS) of the soft tis-
sues are usually situated in the deep soft tissues of the
lower extremity, particularly the thigh [1]. It is seen in a
young or middle aged adult and is more common in the
male. Though they are sporadically seen in other areas like
the chest wall or shoulder they are very rarely reported in
an intra-abdominal location. We report a 37-year old man
with a giant intra-abdominal low grade fibromyxoid sar-
coma measuring 21 cm in size; which was mistaken for a
possible hemangioma of the liver on CT scan.
Case report
A 37 year old man noticed a mass in the epigastric region
since four months and dull non radiating pain in the epi-
gastrium since a month and a half. A few distended veins
were seen over the abdominal wall. Abdominal examina-
tion revealed a non tender firm intra-abdominal mass in
the epigastrium moving with respiration. A doubtful lat-
eral mobility was present. An ultrasound study of the
abdomen showed a large well encapsulated mass in the
left lobe of liver with caudal exophytic expansion [Fig 1].
CT scan demonstrated the lesion extrinsically indenting
stomach showing initial peripheral enhancement with
centripetal filling on time delay [Fig 2]. There was no cal-
cification. The mass was situated between the anterior
abdominal wall and liver; but in close relation to the lat-
ter. In view of these findings, the possibility of a sub cap-
sular mass, probably a hemangioma on the anterior
surface of the left lobe of liver was considered. Biochemi-
cal and hematological investigations were within normal
limits including liver function tests.
A pre-operative fine needle aspiration was not done as
there was a suspicion of hemangioma. A diagnostic lapar-
oscopy was planned to visualize the location of the tumor
and its relation to other organs. It was decided that the
surgical plan would be based on the laparoscopic find-
ings. If the lesion were found to arise from the liver or if
the excision of the tumor necessitated removal of a
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segment of liver, it was decided to biopsy the lesion and
plan a definitive surgery later. Laparoscopy revealed a
large mass lesion situated between the leaves of the falci-
form ligament abutting against the anterior surface of the
liver; but the liver per se was normal and free from the
tumor. A number of enlarged tortuous blood vessels were
seen running from the anterior abdominal wall to the
mass. Anterior abdominal wall was incised and the tumor
accessed through a supra-umbilical incision. The laparo-
scope also assisted in identifying the tortuous vessels lim-
iting the intra-operative blood loss. Wide excision was
completed. As it was desirable to perform an excision with
intact capsule, a laparoscopic excision was not attempted.
The globular bosselated well encapsulated mass [Fig 3, 4]
measuring 21 × 16 × 10 cm was situated between the
leaves of the falciform ligament with neither involvement
of the abdominal wall nor the liver. A frozen section study
was not considered as the surgery would not have been
different if the report were to be either benign or malig-
nant. Cut section showed a grayish white appearance with
focal areas of hemorrhage [Fig 5]. Post operative recovery
was uneventful. Histologically, on initial evaluation, the
mass appeared to be composed of interlacing fascicles of
spindle shaped fibroblasts with cartwheel arrangement
[Fig 6, 7] suggesting a possibility of fibrous histiocytoma.
However, further evaluation with multiple sections
showed a tumor with moderate to low cellularity. The
tumor was composed of bland spindle shaped cells with
small hyperchromatic oval to tapering nuclei, containing
finely clumped chromatin with palely eosinophilic cyto-
plasm. The cells showed mild nuclear pleomorphism with
little mitotic activity. The cells were deposited in a variably
Ultrasound study of abdomen showing the mass in close relation to left lobe of liver Figure 1
Ultrasound study of abdomen showing the mass in close relation to left lobe of liver.BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/7
Page 3 of 7
(page number not for citation purposes)
fibrous and myxoid stroma having stellate cells [Fig 8].
The cells showed whorled arrangement in a random man-
ner. Perivascular hypercellularity was noted in some areas
[Fig 9]. Based on these features, the tumor was diagnosed
as low grade fibromyxoid sarcoma. Immunohistochemis-
try was performed to confirm the diagnosis. The neo-
plasm stained strongly and diffusely for vimentin [Fig 10].
Staining for other markers including CD 34, CD 68,
smooth muscle actin and S 100 were negative [Fig 11].
Conclusion
LGFMS was identified as a distinct entity in 1987 [2].
Though patients as young as 3 years and as old as 78 years
have been diagnosed with this tumor, it commonly
afflicts young to middle aged adults, males more than
females [1,3–5].
Dragging of Glisson's capsule due to the large size proba-
bly accounts for pain in the present case as these are usu-
ally painless slowly growing masses. This mass was
mistaken for a hemangioma for reasons cited earlier.
Hence a pre-operative cytological diagnosis was not possi-
ble. In addition, needle aspiration study is not specific for
diagnosis [6]. This problem of diagnosis was partly cir-
cumvented by laparoscopy. The surgical plan was based
on the laparoscopic findings and it helped in anatomic
localization of the lesion. Further, the identification of
large tortuous vessels in the vicinity of the tumor helped
in reducing the hemorrhage at surgery. This vascular
CT scan of the abdomen shows the close relation of mass to abdominal wall and liver Figure 2
CT scan of the abdomen shows the close relation of mass to abdominal wall and liver. Peripheral enhancement of contrast can 
also be appreciated.BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/7
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supply of the tumor accounts for the peripheral enhance-
ment which led us to suspect a possible subcapsular
hemangioma of the liver.
LGFMS usually arises in the deep soft tissue of the lower
extremity particularly the thigh [1,7]. Many of them arise
in the skeletal muscle while some of them are confined to
subcutaneous tissue [1]. Although this patient did not
show invasion of surrounding tissues on microscopy,
these tumors could have extensive infiltration to sur-
rounding tissues even when the tumor is grossly well cir-
cumscribed. These tumors have been described in
locations like the chest wall, axilla, shoulder, inguinal
region, buttock and the neck apart from thigh [1,8–10].
Rare reports include those in the retroperitoneum, the
small bowel mesentery, pelvis and the mediastinum [11–
15]. Though a large LGFMS has been reported to arise
Post operative specimen showing bosselated appearance  with intact capsule (anterior view) Figure 3
Post operative specimen showing bosselated appearance 
with intact capsule (anterior view).
Specimen showing tumor covered with falciform ligament  and the tied ligamentum teres which is indicated by bold  arrow (posterior view) Figure 4
Specimen showing tumor covered with falciform ligament 
and the tied ligamentum teres which is indicated by bold 
arrow (posterior view).
Cut section of the tumor showing a fleshy mass with some  areas of hemorrhage Figure 5
Cut section of the tumor showing a fleshy mass with some 
areas of hemorrhage.
Photomicrograph of the mass showing spindle cells arranged  in storiform pattern as seen with low magnification (100X) Figure 6
Photomicrograph of the mass showing spindle cells arranged 
in storiform pattern as seen with low magnification (100X). 
Staining is done with hematoxylin and eosin.BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/7
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from the abdominal wall [16], it has not been reported in
the falciform ligament.
Immunohistochemically, the tumor cells stain strongly
and diffusely for vimentin [1]. Rarely, focal immunoreac-
tivity could be seen for smooth muscle actin, desmin or
cytokeratin [1,17]. Though CD 34 is negative, one case of
diffuse staining has been reported [18]. LGFMS with giant
rosettes has been identified as a separate entity but there
are arguments to consider them as same tumor with some
varying features on microscopy [3,19]. In two LGFMS, no
abnormal DNA content or chromosomal aberrations were
noted but cytogenetic analysis revealed a ring chromo-
some in another report [20,21]. In the present case, the
cells expressed vimentin but there was no immunoreactiv-
ity with other markers.
Photomicrograph of the mass with high magnification (400X) Figure 7
Photomicrograph of the mass with high magnification (400X). 
Staining is done with hematoxylin and eosin.
Photomicrograph showing bland spindle shaped cells depos- ited in a variably fibrous and myxoid stroma (100X) Figure 8
Photomicrograph showing bland spindle shaped cells depos-
ited in a variably fibrous and myxoid stroma (100X). Hema-
toxylin and eosin stain.
Photomicrograph showing perivascular hypercellularity  (400X) Figure 9
Photomicrograph showing perivascular hypercellularity 
(400X). Hematoxylin and eosin stain.
Immunohistochemistry: Tumor immunoreactive to vimentin Figure 10
Immunohistochemistry: Tumor immunoreactive to vimentin.BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/7
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LGFMS must be distinguished from myxofibrosarcoma as
their clinical behaviors are different with LGFMS likely to
metastasize more often [22]. The latter lacks areas of
fibrous stroma, is uniformly myxoid and in addition it
does not show whorled arrangement of tumor cells [12].
Other malignant tumors that need to be distinguished
from LGFMS include malignant peripheral nerve sheath
tumor and spindle cell liposarcoma [1]. More often these
lesions are mistaken for benign lesions like myxoid neu-
rofibroma, desmoid fibromatosis, perineuroma or nodu-
lar fascitis [1,23]. The initial evaluation led us to believe
that the tumor was a fibrous histiocytoma. However, with
the study of more sections and the help of a reference
pathologist, the tumor was diagnosed as LGFMS. The
other lesions described above have been excluded in the
present case by microscopic findings and
immunohistochemistry.
These tumors have been reported to recur and metastasize
[1,10,24]. These tumors have recurred as early as 6
months to as late as 50 years in 65% of patients. Metasta-
sis also has been reported to occur frequently with lung
being a common site. These tumors have a protracted
course even after metastasis. Interestingly, in a larger
study, only 5% metastasis has been reported attributing
this to prospectively following up a low grade sarcoma
while earlier studies have worked back on a metastatic
disease [3]. Although a satisfactory wide excision with an
intact capsule was possible, as the tumor was large and
deep seated, this patient is kept under follow-up. Patient
is recurrence free at one year. Adjuvant radiation was not
considered in view of the peculiar position of the tumor.
Responses to chemotherapy have been poor and with the
limited experience must be considered investigational.
Even with advent of many imaging modalities, in certain
situations like the one described, a cytopathological diag-
nosis may not be technically feasible. Diagnostic laparos-
copy would be very useful for anatomic localization.
Proper histopathologic evaluation of the tumor and
immunohistochemistry is necessary for accurate diagno-
sis. Exclusion of other similar appearing tumors is
essential.
List of abbreviations used
LGFMS: Low grade fibromyxoid sarcoma
Authors' contributions
KH was the principal clinician who planned the evalua-
tion and procedure, in addition to conceptualizing and
drafting the article.
ACA performed the laparoscopy
NKA was the pathologist who evaluated the specimen.
All authors read and approved the final manuscript.
Acknowledgement
Dr. Rekha V Kumar, Associate Professor of Pathology at the Kidwai 
Memorial Institute of Oncology (A Regional Cancer Center), Bangalore, 
INDIA was the reference pathologist. We wish to thank her for helping us 
with the pathologic study of the tumor including the immunohistochemical 
study.
"Written consent was obtained from the patient for publication of the 
patient's details."
References
1. Weiss SW and Goldblum JR: Benign fibrohistiocytic tumors. In
Soft tissue tumors 42001:409-39.
2. Evans HL: Low-grade fibromyxoid sarcoma. A report of two
metastasizing neoplasms having a deceptively benign
appearance. Am J Clin Pathol 1987, 88(5):615-9.
3. Folpe AL, Lane KL, Paull G and Weiss SW: Low-grade fibromyxoid
sarcoma and hyalinizing spindle cell tumor with giant
rosettes: a clinicopathologic study of 73 cases supporting
their identity and assessing the impact of high-grade areas.
Am J Surg Pathol 2000, 24(10):1353-60.
4. Kataoka Y, Matsuda M, Katsura T, Tanaka K, Ebara H, Yoshida F,
Takaba E and Takimoto M: Case of low-grade fibromyxoid sar-
coma [in Japanese].  Nippon Naika Gakkai Zasshi 1997,
86(8):1458-60.
5. Canpolat C, Evans HL, Corpron C, Andrassy RJ, Chan K, Eifel P,
Elidemir O and Raney B: Fibromyxoid sarcoma in a four-year-
old child: case report and review of the literature. Med Pediatr
Oncol 1996, 27(6):561-4.
6. Lindberg GM, Maitra A, Gokaslan ST, Saboorian MH and Albores-
Saavedra J: Low grade fibromyxoid sarcoma: fine-needle aspi-
ration cytology with histologic, cytogenetic, immunohisto-
chemical, and ultrastructural correlation.  Cancer 1999,
87(2):75-82.
7. Ugai K, Kizaki T, Morimoto K and Sashikata T: A case of low-grade
fibromyxoid sarcoma of the thigh.  Pathol Int 1994, 44(10–
11):793-9.
Immunohistochemistry: Tumor non reactive with CD 34 (a),  CD 68 (b), S 100 (c) and smooth muscle actin (d) Figure 11
Immunohistochemistry: Tumor non reactive with CD 34 (a), 
CD 68 (b), S 100 (c) and smooth muscle actin (d).Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Surgery 2003, 3 http://www.biomedcentral.com/1471-2482/3/7
Page 7 of 7
(page number not for citation purposes)
8. Husek K, Janicek P and Jelinek O: Low grade malignant fibro-
myxoid sarcoma [In Czech with English abstract]. Cesk Patol
1998, 34(4):139-4.
9. Zamecnik M and Michal M: Low-Grade Fibromyxoid Sarcoma: A
Report of Eight Cases With Histologic, Immunohistochemi-
cal, and Ultrastructural Study. Ann Diagn Pathol 2000, 4:207-17.
10. Devaney DM, Dervan P, O'Neill S, Carney D and Leader M: Low-
grade fibromyxoid sarcoma. Histopathology 1990, 17(5):463-5.
11. Evans HL: Low-grade fibromyxoid sarcoma. A report of 12
cases. Am J Surg Pathol 1993, 17(6):595-600.
12. Goodlad JR, Mentzel T and Fletcher CD: Low grade fibromyxoid
sarcoma: clinicopathological analysis of eleven new cases in
support of a distinct entity. Histopathology 1995, 26(3):229-37.
13. Kaji M, Konishi K, Funaki K, Nukui A, Goka T, Arakawa G, Onishi I,
Kimura H, Maeda K, Yabushita K, Tsuji M, Yamashita H and Miwa A:
A case of low-grade fibromyxoid sarcoma of the small bowel
mesentery [In Japanese]. Nippon Shokakibyo Gakkai Zasshi 1999,
96(6):670-4.
14. Shidham VB, Ayala GE, Lahaniatis JE and Garcia FU: Low-Grade
Fibromyxoid Sarcoma: Clinicopathologic Case Report With
Review of the Literature. Am J Clin Oncol 1999, 22(2):150-5.
15. Takanami I, Takeuchi K and Naruke M: Low-grade fibromyxoid
sarcoma arising in the mediastinum. J Thorac Cardiovasc Surg
1999, 118(5):970-1.
16. van den Bossche MR and Van Mieghem H: Low-grade fibromyxoid
sarcoma. Oncology 2000, 58(3):207-9.
17. Fukunaga M, Ushigome S and Fukunaga N: Low-grade fibromyxoid
sarcoma. Virchows Archiv 1996, 429(4–5):301-3.
18. Nichols GE and Cooper PH: Low-grade fibromyxoid sarcoma:
case report and immunohistochemical study. J Cutan Pathol
1994, 21(4):356-62.
19. Lane KL, Shannon RJ and Weiss SW: Hyalinizing spindle cell
tumor with giant rosettes: a distinctive tumor closely resem-
bling low-grade fibromyxoid sarcoma. Am J Surg Pathol 1997,
21(12):1481-8.
20. Mezzelani A, Sozzi G, Nessling M, Riva C, Della Torre G, Testi MA,
Azzarelli A, Pierotti MA, Lichter P and Pilotti S: Low grade fibro-
myxoid sarcoma. a further low-grade soft tissue malignancy
characterized by a ring chromosome. Cancer Genet Cytogenet
2000, 122(2):144-8.
21. Akoi T, Hisaoka M, Kouho H, Hashimoto H and Nakata H: Inter-
phase cytogenetic analysis of myxoid soft tissue tumors by
fluorescence in situ hybridization and DNA flow cytometry
using paraffin embedded tissue. Cancer 1997, 79:284-93.
22. Mentzel T, Katenkamp D and Fletcher CD: Low malignancy myxo-
fibrosarcoma versus low malignancy fibromyxoid sarcoma.
Distinct entities with similar names but different clinical
course [in German with English abstract].  Pathologe 1996,
17(2):116-21.
23. Hollowood K and Fletcher CD: Soft tissue sarcomas that mimic
benign lesions. Semin Diagn Pathol 1995, 12(1):87-97.
24. Dvornik G, Barbareschi M, Gallotta P and Palma PD: Low grade
fibromyxoid sarcoma. Histopathology 1997, 30(3):274-6.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2482/3/7/prepub